Tiziana Life Sciences PLC (NASDAQ:TLSA)

4.84
Delayed Data
As of 3:59pm ET
 +0.38 / +8.52%
Today’s Change
0.62
Today|||52-Week Range
12.17
+348.15%
Year-to-Date
Tiziana submits patent application for expanded use of Foralumab in COVID-19
Jul 31 / Seeking Alpha - Paid Partner Content
BLNK, PEIX, GTX and QEP among midday movers
Jul 30 / Seeking Alpha - Paid Partner Content
BLNK, PEIX, GTX and BEP among midday movers
Jul 30 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close4.46
Today’s open4.42
Day’s range4.42 - 4.90
Volume24,314
Average volume (3 months)1,339,604
Market cap$490.7M
Data as of 3:59pm ET, 08/13/2020

Growth & Valuation

Earnings growth (last year)-8.00%
Earnings growth (this year)-4.40%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
APTOAptose Biosciences I...+0.21+4.34%
RIGLRigel Pharmaceutical...+0.00+0.20%
PFNXPfenex Inc-0.09-0.70%
VYGRVoyager Therapeutics...+0.18+1.62%
Data as of 3:59pm ET, 08/13/2020

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
London, Greater London

Forecasts